Cost effectiveness and cancer drugs.

[PDF] wiley.comFull View

The impact of cancer drug wastage on economic evaluations

J Truong, MC Cheung, H Mai, J Letargo, A Chambers… - Cancer, 2017 - Wiley Online Library
BACKGROUND The objective of this study was to determine the impact of modeling cancer
drug wastage in economic evaluations because wastage can result from single‐dose vials …
被引用次数：19 相关文章 所有 4 个版本
[PDF] wiley.comFull View

Lack of correlation between the costs of anticancer drugs and clinical benefits in Japan

E Satoh, Y Sasaki, R Ohkuma, T Takahashi… - Cancer …, 2018 - Wiley Online Library
Both overall survival (OS) and progression‐free survival (PFS) are primary endpoints of
phase III studies of new anticancer drugs. Medical care expenditures, especially oncology …
被引用次数：8 相关文章 所有 7 个版本

Linking the price of cancer drug treatments to their clinical value

L Gozzo, A Navarria, V Drago, L Longo… - Clinical drug …, 2016 - Springer
Abstract Background and Objective Appropriate pricing of medications is one of the ultimate
goals for decision makers, but reliable data on the risk/benefit ratio are often lacking when a …
被引用次数：11 相关文章 所有 7 个版本
[PDF] semanticscholar.org

[PDF][PDF] Journal Homepage:-www. journalijar. com

M Athira, S Nongthongbam, SK Sinha, NM Devi - pdfs.semanticscholar.org
Pharmacoeconomics has been defined as “the description and analysis of the costs of drug
therapy to healthcare systems and society.” Costs are of different types direct, indirect and …
相关文章

[引用][C] Reply to JE Battley et al

DG Pfister, SS Baxi - Journal of Clinical Oncology, 2014 - ascopubs.org
1. Kantarjian HM, Fojo T, Mathisen M, et al: Cancer drugs in the United States: Justum
pretium—The just price. J Clin Oncol 31: 3600-3604, 2013 2. Pfister DG: The just price of …
被引用次数：1 相关文章 所有 3 个版本